In the current study, we examined the mutational status of the three epigenetic regulatory genes (IDH1/2, DNMT3A) and the three splicing factor genes (SF3B1, SRSF2, and U2AF1) in 81 MDS-RAEB patients. This evidence concerns the gene SF3B1 and myelodysplastic syndrome with excess blasts.